Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat. - Archive ouverte HAL Access content directly
Journal Articles PLoS ONE Year : 2012

Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat.

(1) , (1) , (1) , (1) , (2) , (3, 4) , (1) , (1) , (1) , (1, 5)
1
2
3
4
5

Abstract

Ischemia/reperfusion injury occurring during liver transplantation is mainly due to the generation of reactive oxygen species (ROS) upon revascularization. Thus, delivery of antioxidant enzymes might reduce the deleterious effects of ROS and improve liver graft initial function. Mangafodipir trisodium (MnDPDP), a contrast agent currently used in magnetic resonance imaging of the liver, has been shown to be endowed with powerful antioxidant properties. We hypothesized that MnDPDP could have a protective effect against liver ischemia reperfusion injury when administrated to the donor prior to harvesting. Livers from Sprague Dawley rats pretreated or not with MnDPDP were harvested and subsequently preserved for 24 h in Celsior® solution at 4°C. Organs were then perfused ex vivo for 120 min at 37°C with Krebs Henseleit solution. In MnDPDP (5 µmol/kg) group, we observed that ATP content was significantly higher at the end of the cold preservation period relative to untreated group. After reperfusion, livers from MnDPDP-treated rats showed better tissue integrity, less hepatocellular and endothelial cell injury. This was accompanied by larger amounts of bile production and higher ATP recovery as compared to untreated livers. The protective effect of MnDPDP was associated with a significant decrease of lipid peroxidation, mitochondrial damage, and apoptosis. Interestingly, MnDPDP-pretreated livers exhibited activation of Nfr2 and HIF-1α pathways resulting in a higher catalase and HO-1 activities. MnDPDP also increased total nitric oxide (NO) production which derived from higher expression of constitutive NO synthase and lower expression of inducible NO synthase. In conclusion, our results show that donor pretreatment with MnDPDP protects the rat liver graft from cold ischemia/reperfusion injury and demonstrate for the first time the potential interest of this molecule in the field of organ preservation. Since MnDPDP is safely used in liver imaging, this preservation strategy holds great promise for translation to clinical liver transplantation.
Fichier principal
Vignette du fichier
journal.pone.0050235.pdf (648.44 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-00864193 , version 1 (20-09-2013)

Identifiers

Cite

Ismail Ben Mosbah, Yann Mouchel, Julie Pajaud, Catherine Ribault, Catherine Lucas, et al.. Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat.. PLoS ONE, 2012, 7 (11), pp.e50235. ⟨10.1371/journal.pone.0050235⟩. ⟨inserm-00864193⟩
276 View
1433 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More